Founded in 2012, Wandercraft is a French company that has pioneered realistic and autonomous walking exoskeletons. Wandercraft’s team works at the cutting edge of walking robotics, in partnership with the leading medical teams and dynamic robotics laboratories in both Europe and USA. In France, Wandercraft works alongside the Kerpape CMRRF and the Centre HOPALE-Jacques Calvé on exoskeleton development, as well as with the Pionsat CMPR APAJH which is investigating clinically, the effects of the exoskeleton on the rehabilitation of the standing and walking exercises. It has received numerous awards and its ambition is supported by prestigious investors.
The team is leading the field in dynamic walking algorithms, artificial intelligence and walking robotics technology. The development of a personal exoskeleton is also underway with the aim, within a few years, of improving the mobility of millions of people with reduced mobility, at home and in their daily lives.
Walking exoskeletons are robotic legs that fit the morphology of the lower limbs and pelvis of patients with locomotor impairment. They allow people with complete paraplegia to stand up and walk during rehabilitation exercises.
Improving treatments for walking impaired people
The Atalante exoskeleton allows people with severe walking impairment to stand up and walk during rehabilitation exercises, without crutches, while facilitating the work of health professionals in the establishments in which it is available.
“With a physio, the patient moves as he or she can. With Wandercraft exoskeleton, they immediately adopt the right walking pattern, which allows the right information to be sent to the brain," says Julie Daniel, rehabilitation officer at Kerpape.
Atalante is designed to enable intensive motor work, the enhancement of neuroplasticity, and a strong commitment of the patient during the treatments.
Wandercraft has developed the second generation of exoskeletons, which self-balance without crutches. Capable of walking hands-free and in a realistic manner, in harmony with the patient, they allow us to envisage intensive treatments with the benefits of a realistic posture and locomotion. They pave the way for the restoration of mobility in everyday life.
Their use to assist post-stroke walking rehabilitation is being clinically evaluated.
Matthieu Masselin, President and co-founder of Wandercraft, said: “We are delighted to introduce Atalante autonomous walking exoskeleton for the first time at the ARAB HEALTH trade show; this will be an opportunity for us to meet and exchange ideas with healthcare professionals in a region where technological innovation and patient experience are at the heart of care strategy. We are working at the cutting edge of robotics and medicine to bring profoundly innovative tools to healthcare professionals. The path to improving mobility for people with reduced mobility is now open. "